Arbutus Biopharma (ABUS) Revenue (2013 - 2026)
Arbutus Biopharma's Revenue came in at $1.01 million for Q2 2026, down 90.6% from $10.74 million a year earlier and down 99.4% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Revenue (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arbutus Biopharma reported Revenue of $181.72 million; for FY2025, it came in at $14.08 million, up 128.2% from FY2024.
- Revenue carries a five-year compound annual growth rate of 15.3% (FY2020 to FY2025).
- Going back by year, Revenue was $6.17 million in FY2024 (-66.0%), $18.14 million in FY2023 (-53.5%), $39.02 million in FY2022 (+255.1%) and $10.99 million in FY2021 (+58.9%).
- The five-year range for quarterly Revenue is $529,000 (Q3 2025) to $179.13 million (Q1 2026).
- Year-over-year, Revenue increased in two of the last seven quarters, with growth averaging 36.5%.
- The fastest year-over-year change in Revenue over five years came in Q2 2025 (growth of 522.2%), and the weakest in Q2 2026 (a decline of 90.6%).
- Business Quant data shows ABUS's Revenue at $179.13 million (Q1 2026), $1.05 million (Q4 2025) and $529,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | 1.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 179.13 Mn |
| Dec 31, 2025 | 1.05 Mn |
| Sep 30, 2025 | 529,000.00 |
| Jun 30, 2025 | 10.74 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.53 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 4.65 Mn |
| Mar 31, 2023 | 6.69 Mn |
| Dec 31, 2022 | 6.25 Mn |
| Sep 30, 2022 | 5.95 Mn |
| Jun 30, 2022 | 14.24 Mn |
| Mar 31, 2022 | 12.58 Mn |
| Dec 31, 2021 | 3.21 Mn |
| Sep 30, 2021 | 3.34 Mn |
API Access
Arbutus Biopharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();